Rafferty Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-214,425
| Closed | -$750K | – | 1153 |
|
|
2024
Q3 | $750K | Sell |
214,425
-36,368
| -15% | -$142K | ﹤0.01% | 859 |
|
|
2024
Q2 | $823K | Sell |
250,793
-478,864
| -66% | -$2.1M | ﹤0.01% | 857 |
|
|
2024
Q1 | $5.36M | Buy |
+729,657
| New | +$4.52M | 0.02% | 462 |
|
|
2023
Q3 | – | Sell |
-955,120
| Closed | -$4.55M | – | 1084 |
|
|
2023
Q2 | $4.55M | Sell |
955,120
-438,845
| -31% | -$2.42M | 0.03% | 437 |
|
|
2023
Q1 | $7.95M | Buy |
1,393,965
+967,382
| +227% | +$5.84M | 0.05% | 247 |
|
|
2022
Q4 | $4.3M | Buy |
426,583
+180,108
| +73% | +$3.38M | 0.04% | 410 |
|
|
2022
Q3 | $5.52M | Buy |
246,475
+53,651
| +28% | +$1.55M | 0.06% | 321 |
|
|
2022
Q2 | $4.78M | Buy |
192,824
+33,434
| +21% | +$922K | 0.04% | 283 |
|
|
2022
Q1 | $6.18M | Buy |
159,390
+52,122
| +49% | +$2.02M | 0.04% | 321 |
|
|
2021
Q4 | $6.28M | Buy |
107,268
+61,723
| +136% | +$3.5M | 0.03% | 287 |
|
|
2021
Q3 | $2.7M | Buy |
45,545
+16,478
| +57% | +$1.29M | 0.02% | 538 |
|
|
2021
Q2 | $2.52M | Sell |
29,067
-55,708
| -66% | -$4.49M | 0.02% | 595 |
|
|
2021
Q1 | $6.99M | Buy |
84,775
+67,811
| +400% | +$6.5M | 0.05% | 224 |
|
|
2020
Q4 | $1.54M | Sell |
16,964
-42,159
| -71% | -$2.62M | 0.02% | 439 |
|
|
2020
Q3 | $2.36M | Buy |
59,123
+28,058
| +90% | +$980K | 0.03% | 367 |
|
|
2020
Q2 | $1.07M | Buy |
+31,065
| New | +$926K | 0.02% | 525 |
|
|
2020
Q1 | – | Sell |
-60,015
| Closed | -$1.17M | – | 678 |
|
|
2019
Q4 | $1.17M | Sell |
60,015
-95,601
| -61% | -$1.52M | 0.02% | 514 |
|
|
2019
Q3 | $2.42M | Buy |
155,616
+49,267
| +46% | +$944K | 0.04% | 294 |
|
|
2019
Q2 | $2.16M | Sell |
106,349
-51
| -0% | -$919 | 0.04% | 401 |
|
|
2019
Q1 | $1.87M | Buy |
+106,400
| New | +$1.68M | 0.03% | 420 |
|
Other funds holding FATE
RG
BG
DM
JJ
BBA
EC
